Department of Diagnostic Medicine, University of Texas at Austin, Austin, Texas.
Livestrong Cancer Institutes, University of Texas at Austin, Austin, Texas.
Cancer. 2019 Nov 1;125(21):3828-3835. doi: 10.1002/cncr.32347. Epub 2019 Jul 22.
The incidence of colorectal cancer (CRC) in adults younger than 50 years has increased in the United States over the past decades according to Surveillance, Epidemiology, and End Results data. National guidelines conflict over beginning screening at the age of 45 or 50 years.
This was a retrospective study of National Cancer Data Base data from 2004 to 2015. The Cochran-Armitage test for trend was used to assess changes in the proportion of cases diagnosed at an age younger than 50 years.
This study identified 130,165 patients diagnosed at an age younger than 50 years and 1,055,598 patients diagnosed at the age of 50 years or older. The proportion of the total number of patients diagnosed with CRC at an age younger than 50 years rose (12.2% in 2015 vs 10.0% in 2004; P < .0001). Younger adults presented with more advanced disease (stage III/IV; 51.6% vs 40.0% of those 50 years old or older). Among men, diagnosis at ages younger than 50 years rose only in non-Hispanic whites (P < .0001), whereas among women, Hispanic and non-Hispanic whites had increases in younger diagnoses over time (P < .05). All income quartiles had a proportional increase in younger adults over time (P < .001), with the highest income quartile having the highest proportion of younger cases. The proportion of younger onset CRC cases rose in urban areas (P < .001) but did not rise in rural areas.
The proportion of persons diagnosed with CRC at an age younger than 50 years in the United States has continued to increase over the past decade, and younger adults present with more advanced disease. These data should be considered in the ongoing discussion of screening guidelines.
根据监测、流行病学和最终结果数据,过去几十年来,美国 50 岁以下成年人的结直肠癌(CRC)发病率有所上升。国家指南在 45 岁或 50 岁开始筛查的问题上存在冲突。
这是一项对 2004 年至 2015 年国家癌症数据库数据的回顾性研究。采用 Cochran-Armitage 趋势检验来评估年龄小于 50 岁的病例比例的变化。
本研究共纳入 130165 例年龄小于 50 岁和 1055598 例年龄大于等于 50 岁的患者。年龄小于 50 岁的 CRC 患者总人数的比例有所上升(2015 年为 12.2%,2004 年为 10.0%;P<.0001)。年轻患者的疾病更晚期(III/IV 期;51.6%比 50 岁及以上患者的 40.0%)。在男性中,只有非西班牙裔白人的 50 岁以下诊断率有所上升(P<.0001),而在女性中,西班牙裔和非西班牙裔白人的年轻诊断率随时间呈上升趋势(P<.05)。所有收入四分位数的年轻成年人比例随时间呈上升趋势(P<.001),收入最高的四分位数的年轻病例比例最高。城市地区年轻发病 CRC 病例的比例上升(P<.001),但农村地区的比例没有上升。
美国 50 岁以下诊断为 CRC 的人数在过去十年中持续增加,且年轻患者的疾病更晚期。这些数据应在正在进行的筛查指南讨论中加以考虑。